The new ASCO–Society of Surgical Oncology Guideline recommended testing all newly diagnosed patients with breast cancer for BRCA1/2 mutation ≤65 years and select patients >65 years based on personal history, family history. This evidence concerns the gene BRCA1 and breast cancer.